— New Studies Expand Cesalatamig into Biomarker-driven Precision Immuno-oncology Strategies — Cesalatamig is Also Being Evaluated in Ongoing Phase 2 Studies in the...
URUMQI, China, Sept. 5, 2025 /PRNewswire/ -- Chanson International Holding (Nasdaq: CHSN) (the "Company" or "Chanson"), a provider of bakery, seasonal, and beverage products...
CHARLOTTE, N.C., Sept. 5, 2025 /PRNewswire/ -- EverHive, a global leader in contingent workforce Managed Service Provider (MSP) solutions, announced its expansion into the...
Custom Integrators Choose SKYWORTH for Superior Brightness, Proven Durabilityand Competitive Value in Outdoor Entertainment DENVER, Sept. 5, 2025 /PRNewswire/ -- At CEDIA Expo 2025...